癌症研究
胶质2
小RNA
腺癌
基因沉默
癌变
生物
肺癌
克隆形成试验
刺猬信号通路
细胞凋亡
顺铂
信号转导
癌症
病理
医学
细胞生物学
化疗
基因
遗传学
作者
Carina Seidl,Katrin Panzitt,Alexandra Bertsch,Luka Brčić,Sandra Schein,Maximilian Mack,Katharina Leithner,Felix Prinz,Horst Olschewski,Karin Kornmueller,Andelko Hrzenjak
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2019-11-05
卷期号:469: 266-276
被引量:77
标识
DOI:10.1016/j.canlet.2019.10.044
摘要
Abstract Lung cancer is one of the deadliest cancers worldwide. Late diagnosis at an advanced, inoperable stage makes chemotherapy a treatment of choice, yet, with low response rates. The hedgehog signaling pathway (HHSP) is often reactivated in cancer. We identified miR-182-5p as a regulator of GLI2, a transcriptional regulator of the HHSP, and explored the role of the miR-182-5p/GLI2 axis in carcinogenesis and cisplatin resistance of lung adenocarcinoma (LADC). Expression of miRNAs and target genes was analyzed by RT-qPCR, expression of the GLI-protein family in LADC and adjacent lung tissue (n = 27 pairs) by immunohistochemistry. MiR-182-5p was manipulated, and data were generated by immunoblotting, immunofluorescence, apoptosis, proliferation/viability, dual-luciferase-, and colony forming assays. MiR-182-5p was down-regulated in cisplatin-resistant LADC cells and directly targeted GLI2. Interference with miR-182-5p or GLI2 silencing resulted in modulation of cell proliferation, clonogenic potential, and cisplatin-sensitivity. HHSP was markedly reactivated in LADC tissue compared to adjacent non-malignant lung tissue. Our results indicate that the miR-182-5p/GLI2 axis modulates tumorigenesis and cisplatin-resistance in LADC cells, by influencing the HHSP. Therefore, this axis might be considered as a potential biomarker and future therapeutic target in LADC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI